Sotac Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue26.7226.3526.8025.5027.35
Expenses26.0424.6526.5024.200.60
EBITDA2.143.521.532.470.00
EBIT1.362.460.651.720.00
Profit Before Tax0.681.480.301.300.42
Net Profit0.210.881.511.350.42
Financial Ratios
Operating Profit Margin8.02%12.78%5.78%9.74%9.36%
Net Profit Margin2.44%4.04%6.20%5.74%1.68%
Earning Per Share (Diluted)0.580.821.491.320.00
Dividends Per Share0.000.000.000.000.00